cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.11409807.v1
title: Detecting a downward shift in a proportion using a geometric CUSUM chart

description: In monitoring an ordered stream of discrete items from a repetitive process, the geometric CUSUM chart may be used to detect sudden shifts from an acceptable level for a process-proportion (<i>p</i>) such as fraction nonconforming. Much of the investigative effort for this CUSUM scheme has been concentrated on the detection of upward shifts, and a recent paper has provided guidance to quality engineers in choosing the parameters (<i>k</i>, <i>h</i>) of such a scheme. In this article, the corresponding task of aiding the choice of parameters for detecting a downward shift is addressed. It is shown, using extensive numerical investigations, that the use of a value for the parameter <i>k</i> based on the Sequential Probability Ratio is not optimal when one is using steady-state evaluation of the detection performance of the CUSUM scheme. Tables are presented listing recommended values of parameters for detection of five sizes of downward shift, for each of 27 in-control levels for <i>p</i> in the range 0.20 to 0.001. Interpolation and extrapolation to find parameter values for other in-control levels of <i>p</i> are also considered, and a range of examples presented. There is an equivalence between a geometric CUSUM scheme and a Bernoulli CUSUM scheme, so that the results of this investigation may also be used in choosing parameter values for a Bernoulli CUSUM chart.
DOI: 10.6084/m9.figshare.11409708.v1
title: Central data set

description: Central data set for: Damsbo-Svendsen, Søren. (Forthcoming). 'How weather experiences strengthen climate change awareness in Europe'.<br>
DOI: 10.6084/m9.figshare.11409675
title: Dataset_S1_Lyons_et_al_Toxins

description: Dataset associated with the analysis in Lyons et al.
DOI: 10.6084/m9.figshare.11409528
title: Data and analysis

description: To generate the plots/analysis in the manuscript, please do the following:- download and extract zip file- open mutatorpaper_dataanalysis.Rproj in Rstudio- on the files pane, open one of the .Rmd files and press knit<br>This should generate a file identical to the html file that we provide, assuming that you have installed the R packages required in each .Rmd file (session info, with package versions, is detailed at the end of each html file). <br>###############folder contents###############<br>##data<br>experimental_data_mutatorPaper.xlsx - results of all experiments shown in the manuscript<br>mullerRatchet_simulationResults.xlsx - results of simulations shown in the manuscript<br>molecularEvolution_data: folder with the results of whole-genome sequence analysis<br><br>##analysis<br>- .Rmd files have code to produce figures/tables in the file name and any statistics relating to those figures/tables<br>- .html files are the (knitted) output of those .Rmd files, which include both code and figures/tables/statistics<br>
DOI: 10.6084/m9.figshare.11409447
title: Dissociating representations of time and number in reinforcement rate learning by GluA1 AMPAR subunit deletion in mice

description: Data for Experiments 1-8 in "Dissociating representations of time and number in reinforcement rate learning by GluA1 AMPAR subunit deletion in mice". · The data for each experiment is provided in separate tabs. · The first three columns of each tab list the ID, sex and genotype of the subjects.· For Experiments 1-6 the fourth column of each tab lists the modality (auditory/visual) of one of the cue conditions in the experiment. This factor was included in the analyses in order to control for variance caused by the counterbalancing of modality across conditions.· For Experiments 1-7 the difference score for each condition per block is listed as rate per minute. The column title indicates the cue condition and block.· For Experiment 8, columns D-AG list the mean rate of responding for each second of the nonreinforced probe trials. Response rates are per second. Column AH lists the slopes for normalized response rates for the first 10 s all trials. Column AI lists the measure of spread taken for Gaussian curve fitting analysis across response rates for the probe trials. · The data for each experiment is provided in separate tabs. · The first three columns of each tab list the ID, sex and genotype of the subjects.· For Experiments 1-6 the fourth column of each tab lists the modality (auditory/visual) of one of the cue conditions in the experiment. This factor was included in the analyses in order to control for variance caused by the counterbalancing of modality across conditions.· For Experiments 1-7 the difference score for each condition per block is listed as rate per minute. The column title indicates the cue condition and block.· For Experiment 8, columns D-AG list the mean rate of responding for each second of the nonreinforced probe trials. Response rates are per second. Column AH lists the slopes for normalized response rates for the first 10 s all trials. Column AI lists the measure of spread taken for Gaussian curve fitting analysis across response rates for the probe trials.
DOI: 10.6084/m9.figshare.11409516
title: Metadata record for: Data from a terminated study on iron oxide nanoparticle magnetic resonance imaging for head and neck tumors

description: This dataset contains key characteristics about the data described in the Data Descriptor Data from a terminated study on iron oxide nanoparticle magnetic resonance imaging for head and neck tumors. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format <br> <br> Versioning Note:Version 2 was generated when the metadata format was updated from JSON to JSON-LD. This was an automatic process that changed only the format, not the contents, of the metadata.<br>
DOI: 10.6084/m9.figshare.11409444
title: Land cover raster data of the Italian mountain ranges (Alps & Apennines) for the 1954 - 2012 period

description: <b>Description</b> The dataset is composed by 32 rasters representing land cover maps of 16 landscapes (1954 - 2012 period) divided by mountain region membership (Alps or Apennines) as indicated in the following list:ALPS Bagni – BAN - 1574.3 haMello – MEL- 1433.7 ha Sapè – SAP- 959.4 haPesio – PES- 1599.2 haVentina – VEN - 630.4 haMusella – MUS - 921.4 haVeglia – VEG - 1407.2 haDevero – DEV - 1570.0 haAPENNINESCimone - CIM - 1593.4 haSibillini - SIB - 1601.3 haGran Sasso - GRS - 1602.4 haTerminillo - TER - 1600.7 haMorrone - MOR - 1603.7 haGenzana - GEN - 1603.4 haMonte Mare - MMA - 1604.0 ha Matese - MAT - 1605.4 ha<b><br></b><b>Metadata</b> - Cell Size (X, Y): 1, 1 meters - Coordinate System: WGS84 UTM Zone 32N (EPSG: 32632) - NoData Value: 255 - Data type: 8 Bit unsigned integer - Format: GeoTIFF - Compression: LZW - Land cover classification: object-oriented segmentation and video photointerpretation (Garbarino et al. 2013). - Land class values: 1 = forest, 2 = grassland, 3 = cropland, 4 = human, 5 = unvegetated<br>
DOI: 10.6084/m9.figshare.11409516.v2
title: Metadata record for: Data from a terminated study on iron oxide nanoparticle magnetic resonance imaging for head and neck tumors

description: This dataset contains key characteristics about the data described in the Data Descriptor Data from a terminated study on iron oxide nanoparticle magnetic resonance imaging for head and neck tumors. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format <br> <br> Versioning Note:Version 2 was generated when the metadata format was updated from JSON to JSON-LD. This was an automatic process that changed only the format, not the contents, of the metadata.<br>
DOI: 10.6084/m9.figshare.11409516.v1
title: Metadata record for: Data from a terminated study on iron oxide nanoparticle magnetic resonance imaging for head and neck tumors

description: This dataset contains key characteristics about the data described in the Data Descriptor Data from a terminated study on iron oxide nanoparticle magnetic resonance imaging for head and neck tumors. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format
DOI: 10.6084/m9.figshare.11409429
title: Intraspecific variation in seed traits of Geropogon hybridus

description: Data used in the paper:Variation in morphological traits affects dispersal and seedling emergence in dispersive diaspores of <i>Geropogon hybridus</i><br>American Journal of Botany (AJB-D-19-00308)<i><br></i>
DOI: 10.6084/m9.figshare.11409384
title: Frailty in lung transplantation: a systematic review

description: <b>Introduction</b>: Lung transplantation is an effective treatment for certain types of end-stage lung disease. Frailty is a complex clinical syndrome associated with decreased physiological reserve and an increased risk for suboptimal health outcomes. <b>Area covered</b>: This article reviews the current literature on frailty in lung transplantation, with an emphasis on frailty measures, prevalence and impact of frailty on morbidity and mortality prior to and following lung transplantation. Pubmed, EMBASE, CINAHL and Cochrane systematic review databases were searched to September 2019. The search included the MeSH terms ‘frail elderly’ or ‘frailty’ or ‘sarcopenia’ and ‘lung disease’ or ‘lung transplantation’. Studies were included if: the population were undergoing evaluation for, listed for or received a lung transplant; frailty was prospectively assessed during lung transplant evaluation using systematically defined criteria; used human subjects and; published in English. The prevalence of frailty varied from 0% - 58%. The frailty phenotype and short physical performance battery were the most common measures. Frailty was associated with delisting and death pre-transplantation. Frailty was associated with an increased risk of early mortality post-lung transplantation. <b>Expert opinion</b>: Frailty is identified often in lung transplant candidates and is associated with adverse pre and post-transplantation outcomes. Further research is necessary to identify potential frailty interventions.
DOI: 10.6084/m9.figshare.11409369
title: Was Quetelet’s Average Man Normal?

description: Quetelet’s data on Scottish chest girths are analyzed with eight normality tests. In contrast to Quetelet’s conclusion that the data are fit well by what is now known as the normal distribution, six of eight normality tests provide strong evidence that the chest circumferences are not normally distributed. Using corrected chest circumferences from Stigler, the <i>χ</i><sup>2</sup> test no longer provides strong evidence against normality, but five commonly used normality tests do. The D’Agostino–Pearson <i>K</i><sup>2</sup> and Jarque–Bera tests, based only on skewness and kurtosis, find that both Quetelet’s original data and the Stigler-corrected data are consistent with the hypothesis of normality. The major reason causing most normality tests to produce low <i>p</i>-values, indicating that Quetelet’s data are not normally distributed, is that the chest circumferences were reported in whole inches and rounding of large numbers of observations can produce many tied values that strongly affect most normality tests. Users should be cautious using many standard normality tests if data have ties, are rounded, and the ratio of the standard deviation to rounding interval is small.
DOI: 10.6084/m9.figshare.11409384.v1
title: Frailty in lung transplantation: a systematic review

description: <b>Introduction</b>: Lung transplantation is an effective treatment for certain types of end-stage lung disease. Frailty is a complex clinical syndrome associated with decreased physiological reserve and an increased risk for suboptimal health outcomes. <b>Area covered</b>: This article reviews the current literature on frailty in lung transplantation, with an emphasis on frailty measures, prevalence and impact of frailty on morbidity and mortality prior to and following lung transplantation. Pubmed, EMBASE, CINAHL and Cochrane systematic review databases were searched to September 2019. The search included the MeSH terms ‘frail elderly’ or ‘frailty’ or ‘sarcopenia’ and ‘lung disease’ or ‘lung transplantation’. Studies were included if: the population were undergoing evaluation for, listed for or received a lung transplant; frailty was prospectively assessed during lung transplant evaluation using systematically defined criteria; used human subjects and; published in English. The prevalence of frailty varied from 0% - 58%. The frailty phenotype and short physical performance battery were the most common measures. Frailty was associated with delisting and death pre-transplantation. Frailty was associated with an increased risk of early mortality post-lung transplantation. <b>Expert opinion</b>: Frailty is identified often in lung transplant candidates and is associated with adverse pre and post-transplantation outcomes. Further research is necessary to identify potential frailty interventions.
DOI: 10.6084/m9.figshare.11409360
title: Benchmark datasets

description: Six benchmark datasets for Vamb paper: MetaHIT benchmark dataset from MetaBAT paper and the five CAMI2 toy human short read datasets.<br>This tar is uncompressed and contains FASTA files and numpy .npz depths files.<br>
DOI: 10.6084/m9.figshare.11409369.v1
title: Was Quetelet’s Average Man Normal?

description: Quetelet’s data on Scottish chest girths are analyzed with eight normality tests. In contrast to Quetelet’s conclusion that the data are fit well by what is now known as the normal distribution, six of eight normality tests provide strong evidence that the chest circumferences are not normally distributed. Using corrected chest circumferences from Stigler, the <i>χ</i><sup>2</sup> test no longer provides strong evidence against normality, but five commonly used normality tests do. The D’Agostino–Pearson <i>K</i><sup>2</sup> and Jarque–Bera tests, based only on skewness and kurtosis, find that both Quetelet’s original data and the Stigler-corrected data are consistent with the hypothesis of normality. The major reason causing most normality tests to produce low <i>p</i>-values, indicating that Quetelet’s data are not normally distributed, is that the chest circumferences were reported in whole inches and rounding of large numbers of observations can produce many tied values that strongly affect most normality tests. Users should be cautious using many standard normality tests if data have ties, are rounded, and the ratio of the standard deviation to rounding interval is small.
DOI: 10.6084/m9.figshare.11407830
title: Supplementary Material for: Systematic Assessment of Adult Patients’ Satisfaction with Various Eosinophilic Esophagitis Therapies

description: <b><i>Background and Aims:</i></b> The treatment options for eosinophilic esophagitis (EoE) patients include drugs (proton pump inhibitors [PPIs], swallowed topical corticosteroids [STCs]), elimination diets, and dilation. Given the lack of data, we aimed to assess adult EoE patients’ satisfaction with different EoE-specific treatment modalities. <b><i>Patients and Methods:</i></b> We evaluated therapy satisfaction recalled over a 12-month period using the validated Treatment Satisfaction Questionnaire for Medication that assesses effectiveness, side effects, convenience, and overall satisfaction. The score for each scale ranges from 0 (dissatisfied) to 100 (satisfied). To evaluate satisfaction with nonpharmacologic therapies, the questionnaire was modified and debriefed into three focus groups. The final questionnaire was sent to 147 patients. <b><i>Results:</i></b> The patient response rate was 74%. In the last 12 months, 24, 75, 19, and 9% were treated with PPIs, STCs, elimination diet, and dilation, respectively. Patients identified the following considerations as important for therapy choice: effect on symptoms (89%), effect on esophageal inflammation (76%), side effects (69%), and ease of use (58%). Patients found STCs to be effective (83 points), convenient (83 points), and experienced no side effects when using this therapy. When using STCs alone (43%), overall patient satisfaction was high (86 points). Patients judged PPIs to be most convenient (89 points), STCs to be a bit less convenient (83 points), and diet to be most inconvenient (46 points) of the three therapies examined. <b><i>Conclusions:</i></b> Adult EoE patients consider both therapy effect on symptoms and esophageal inflammation as important criteria when choosing EoE therapy and appear to be satisfied with STC use.
DOI: 10.6084/m9.figshare.11407830.v1
title: Supplementary Material for: Systematic Assessment of Adult Patients’ Satisfaction with Various Eosinophilic Esophagitis Therapies

description: <b><i>Background and Aims:</i></b> The treatment options for eosinophilic esophagitis (EoE) patients include drugs (proton pump inhibitors [PPIs], swallowed topical corticosteroids [STCs]), elimination diets, and dilation. Given the lack of data, we aimed to assess adult EoE patients’ satisfaction with different EoE-specific treatment modalities. <b><i>Patients and Methods:</i></b> We evaluated therapy satisfaction recalled over a 12-month period using the validated Treatment Satisfaction Questionnaire for Medication that assesses effectiveness, side effects, convenience, and overall satisfaction. The score for each scale ranges from 0 (dissatisfied) to 100 (satisfied). To evaluate satisfaction with nonpharmacologic therapies, the questionnaire was modified and debriefed into three focus groups. The final questionnaire was sent to 147 patients. <b><i>Results:</i></b> The patient response rate was 74%. In the last 12 months, 24, 75, 19, and 9% were treated with PPIs, STCs, elimination diet, and dilation, respectively. Patients identified the following considerations as important for therapy choice: effect on symptoms (89%), effect on esophageal inflammation (76%), side effects (69%), and ease of use (58%). Patients found STCs to be effective (83 points), convenient (83 points), and experienced no side effects when using this therapy. When using STCs alone (43%), overall patient satisfaction was high (86 points). Patients judged PPIs to be most convenient (89 points), STCs to be a bit less convenient (83 points), and diet to be most inconvenient (46 points) of the three therapies examined. <b><i>Conclusions:</i></b> Adult EoE patients consider both therapy effect on symptoms and esophageal inflammation as important criteria when choosing EoE therapy and appear to be satisfied with STC use.
DOI: 10.6084/m9.figshare.11407752
title: Rmarkdown code and raw data to figures for Expanding the CRISPR toolbox in Culicine mosquitoes: in vitro validation of novel Pol III promoters

description: Raw data from cell transfection and luciferase assays. Luciferase readings are from Firelfly luciferase normalised against Renilla luciferase control. This is then transformed against a no sgRNA control to produce indirect scales of activity for U6 & 7SK promoters of sgRNA. Data were analysed by GLMMs with a gamma distribution and log link - full analysis code present in Rmarkdown file, along with code to produce the plots for Figure 1 and Figure 2
DOI: 10.6084/m9.figshare.11407749
title: AA vs GC

description: Datafiles used in the study<br>
DOI: 10.6084/m9.figshare.11407752.v1
title: Rmarkdown code and raw data to figures for Expanding the CRISPR toolbox in Culicine mosquitoes: in vitro validation of novel Pol III promoters

description: Raw data from cell transfection and luciferase assays. Luciferase readings are from Firelfly luciferase normalised against Renilla luciferase control. This is then transformed against a no sgRNA control to produce indirect scales of activity for U6 & 7SK promoters of sgRNA. Data were analysed by GLMMs with a gamma distribution and log link - full analysis code present in Rmarkdown file, along with code to produce the plots for Figure 1 and Figure 2
DOI: 10.6084/m9.figshare.11407749.v1
title: AA vs GC

description: Datafiles used in the study<br>
DOI: 10.6084/m9.figshare.11407743
title: scClassifier's tutorial datasets

description: This repository includes two datasets. The first one named pbmc3k.RData is a scRNA-seq dataset of 3,000 human PBMCs generated by 10x Genomics. The second one named immuno_navigator_human_expression.RData is a wrapper of Immuno-Navigator database.
DOI: 10.6084/m9.figshare.11407743.v1
title: scClassifier's tutorial datasets

description: This repository includes two datasets. The first one named pbmc3k.RData is a scRNA-seq dataset of 3,000 human PBMCs generated by 10x Genomics. The second one named immuno_navigator_human_expression.RData is a wrapper of Immuno-Navigator database.
DOI: 10.6084/m9.figshare.11407611
title: Recognition of emotions from facial point-light displays

description: - Eprime files for each participant- A .csv file with all data- A .xls file with the responses to the questionnaires<br><br>
DOI: 10.6084/m9.figshare.11407218
title: Time-of-day variation on performance measures in repeated-sprint tests: a systematic review

description: The lack of standardization of methods and procedures have hindered agreement in the literature related to time-of-day effects on repeated sprint performance and needs clarification. Therefore, the aim of the present study was to investigate and systematically review the evidence relating to time-of-day based on performance measures in repeated-sprints. The entire content of PubMed (MEDLINE), Scopus, SPORTDiscus® (via EBSCOhost) and Web of Science was searched. Only experimental research studies conducted in male adult participants aged ≥18yrs, published in English before June 2019 were included. Studies assessing repeated-sprints between a minimum of two time-points during the day (morning versus evening) were deemed eligible. The primary search revealed that a total of 10 out of 112 articles were considered eligible and subsequently included. Seven articles were deemed strong and three moderate quality. Eight studies found repeated-sprint performance across the first, first few, or all sprints, to increase in favor of the evening. The magnitude of difference is dependent on the modality and the exercise protocol used. The non-motorized treadmill established an average 3.5–8.5% difference in distance covered, average and peak velocity, and average power, across all sprints in three studies and in peak power in two studies. In cycling, power output differed across all sprints by 6.0% in one study and 8.0% for the first sprint only in five studies. All four studies measuring power decrement values (i.e. rate of fatigue) established differences up to 4.0% and two out of five studies established total work to be significantly higher by 8.0%. Repeated-sprint performance is affected by time-of-day with greater performance in the late/early afternoon. The magnitude is dependent on the variable assessed and the mode of exercise. There is a clear demand for more rigorous investigations which control factors that specifically relate to investigations of time-of-day and are specific to the sport of individuals.